...Phase II testing for metastatic triple-negative breast cancer (TNBC) and renal transplant rejection. Dompe and SatRx LLC...

...and Phase II testing to treat breast cancer and prevent renal transplant rejection. Dompe and SatRx LLC...

...this series, in preclinical testing for chronic obstructive pulmonary disease (COPD). Dompe Farmaceutici S.p.A. and SatRx LLC...

...Dompe and SatRx partnered to develop and commercialize Dompe's Reparixin in Russia to improve liver transplantation...
...SatRx is responsible for conducting clinical trials and obtaining regulatory approval in Russia. Dompe said SatRx...
...to disclose details, and SatRx could not be reached. Dompe Farmaceutici S.p.A. , Milan, Italy SatRx LLC...

...Pfizer granted ChemRar's SatRx LLC company exclusive rights outside China to develop and commercialize Pfizer's gosogliptin...

...Pfizer Inc. (NYSE:PFE) granted the SatRx company of ChemRar High Tech Center (Khimki, Russia) exclusive rights...